Clinverse, Inc. Announces Achievement of SSAE Certification

Third-party review validates Clinverse's continued commitment to clients to create and maintain stringent controls on clinical trial payment solutions provided.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Raleigh, NC (PRWEB) February 28, 2013

Clinverse, Inc., a global technology and financial services company for clinical trials, today announced that it has completed the Statement on Standards for Attestation Engagements No. 16 (SSAE 16) Type 1 examination. The examination was performed by 360 Advanced, P.A., a full-service auditing and consulting firm, on the scope of the clinical trial payment solutions offered by Clinverse.

SSAE 16, developed by the American Institute of Certified Public Accountants (AICPA), is the most widely recognized authoritative guidance that provides service organizations with a uniform method for disclosing independently assessed information about the design and operation of internal controls related to their services and security. Companies that complete an annual examination demonstrate a higher level of assurance and operational visibility within the systems and processes as compared to those that do not.

“This is an important milestone for Clinverse,” said Tim Immel, CEO of Clinverse. “We take client data very seriously, and the successful completion of the examination further illustrates our continued commitment to create and maintain stringent controls on our clinical financial solutions to ensure the highest quality and security of services for our clients.”

About Clinverse, Inc.

Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed, ClinPay™ FLS, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of Global sites while supporting payments in 140 different currencies. For more information on how Clinverse can help automate your clinical trial payment process, please visit http://www.clinverse.com.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn